Phobia from scarring: the invisible problem of cutaneous leishmaniasis in the endemic area

Authors

  • Daifullah Al Aboud

DOI:

https://doi.org/10.66344/jpad.23.1.2013.274

References

Phobia. [A page on the Internet].From Wikipedia, the free encyclopedia Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc . [This page was last modified 2011 June 18; cited 2011 June 18] .Available at: http://en.wikipedia.org/wiki/Phobia

Jenerowicz D, Czarnecka-Operacz M, Silny W. Corticosteroid phobia in patients with atopic dermatitis. Wiad Lek. 2005;58(11-12):607-15.

Charman CR, Morris AD, Williams HC. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol. 2000;142:931-6.

Patterson R, Walker CL, Greenberger PA, Sheridan EP. Prednisonephobia. Allergy Proc. 1989;10:423-8.

Hoehn-Saric R. Facial hyperhidrosis-induced social fear alleviated with topiramate. J Clin Psychiatry. 2006;67:1157.

Yim L. Belonephobia--a fear of needles. Aust Fam Physician. 2006;35:623-4.

Downloads

Published

2016-12-09

How to Cite

1.
Aboud DA. Phobia from scarring: the invisible problem of cutaneous leishmaniasis in the endemic area. J Pak Assoc Dermatol [Internet]. 2016Dec.9 [cited 2026Apr.22];23(1):107-8. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/274

Issue

Vol. 23 No. 1 (2013): January - March

Section

Short Communications

License

Submission declaration

Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.

By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.

Most read articles by the same author(s)